Recombinant Mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant Mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 8, Pages e003180
Publisher
BMJ
Online
2021-08-14
DOI
10.1136/jitc-2021-003180
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression
- (2020) Tyler J. Alban et al. Frontiers in Immunology
- Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma
- (2019) Laura Soumoy et al. Cancers
- Advances in cancer immunotherapy 2019 – latest trends
- (2019) Stephan Kruger et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment
- (2018) Suzanne Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses
- (2018) Kristen N. Balogh et al. PLoS One
- Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine
- (2018) Byoung-Jun Kim et al. Frontiers in Immunology
- Blockade of MIF–CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma
- (2018) Carlos R. Figueiredo et al. Frontiers in Immunology
- Combination Cancer Immunotherapy in Hepatocellular Carcinoma
- (2018) Masatoshi Kudo Liver Cancer
- Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis
- (2017) Rajeev K. Shrimali et al. Cancer Immunology Research
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- The biological function and significance of CD74 in immune diseases
- (2016) Huiting Su et al. INFLAMMATION RESEARCH
- MIFallele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis
- (2016) Seung-Ah Yoo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion
- (2016) Balint Otvos et al. STEM CELLS
- How Do Cytotoxic Lymphocytes Kill Cancer Cells?
- (2015) L. Martinez-Lostao et al. CLINICAL CANCER RESEARCH
- Macrophage migration inhibitory factor: A key cytokine and therapeutic target in colon cancer
- (2015) A.N. Gordon-Weeks et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma
- (2014) Camila S Oliveira et al. BMC CANCER
- Induction of T cell responses and recruitment of an inflammatory dendritic cell subset following tumor immunotherapy with Mycobacterium smegmatis
- (2012) Fenella J. Rich et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Macrophage Migration Inhibitory Factor Promotes Tumor Growth and Metastasis by Inducing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2012) K. D. Simpson et al. JOURNAL OF IMMUNOLOGY
- CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer
- (2012) Ying-Xia Zheng WORLD JOURNAL OF GASTROENTEROLOGY
- Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation
- (2011) Claudia A. Dumitru et al. INTERNATIONAL JOURNAL OF CANCER
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice
- (2010) J. C. Markley et al. BLOOD
- Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast
- (2010) Y. Cho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MIF Deficiency Reduces Chronic Inflammation in White Adipose Tissue and Impairs the Development of Insulin Resistance, Glucose Intolerance, and Associated Atherosclerotic Disease
- (2009) Lars Verschuren et al. CIRCULATION RESEARCH
- Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies
- (2009) Marc Pellegrini et al. NATURE MEDICINE
- Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer
- (2008) Xiangdong Xu et al. CANCER LETTERS
- Statistical methods for efficiency adjusted real-time PCR quantification
- (2007) Joshua S. Yuan et al. Biotechnology Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now